Advertisement BioNeutral announces sales and distribution agreement with Menzer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioNeutral announces sales and distribution agreement with Menzer

BioNeutral has entered into sales and distribution agreement with Menzer for the distribution of BioNeutral’s Ogiene line of odor elimination and cleaning products in the UK, Europe and the Middle East.

This agreement is another component of our slate of channel partners that we are strategically aligning ourselves with. Initially Menzer will focus on sales of our Ogiene products for consumer use by distributing to chain store retailers. Menzer also plans to offer our Ogiene line commercially.

Menzer director Scott Dougan noted that the company is delighted to be able to offer its customers in Europe the innovative technology Ogiene provides.

"OGIENE™ will bring something new to the marketplace and we are confident the highly effective range of Odor eliminators and Multipurpose Cleansers will attract consumers across Europe," Dougan added.

BioNeutral president and CEO Mark Lowenthal noted that the company is pleased to have Menzer on board to begin its initial commercialization effort at the consumer level.

"Our OGIENE™ line of odor eliminators and cleaning products carry our unique and proprietary combinational chemistries offering superior performance that we feel will the consumer will respond to. Gaining access to store shelves in the UK and Europe should be a great start for us," Lowenthal added.